Metraipolis › archive › dc_3dba3c618271

Prognostic significance of FT3 levels in hypertrophic cardiomyopathy patients with HFpEF — Europe PMC PMID:40918188

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40918188
DOI
10.3389/fcvm.2025.1546309
License (as archived)
solo-consultazione
Archived
2026-11-10T11:40:22.664Z
SHA-256 of the archived text
f857a1ee9efd4054a9aeb6959c24d7ceff49a2693d3968f63c2d16ab228c7db2
Stable URL of this page
https://metraipolis.com/documento/dc_3dba3c618271

How to cite

Prognostic significance of FT3 levels in hypertrophic cardiomyopathy patients with HFpEF — Europe PMC PMID:40918188 — Europe PMC (en), https://europepmc.org/article/MED/40918188 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3dba3c618271 (Metraipolis archive dc_3dba3c618271, sha256 f857a1ee9efd4054a9aeb6959c24d7ceff49a2693d3968f63c2d16ab228c7db2)
BibTeX
@misc{dc3dba3c618271,
  title = {Prognostic significance of FT3 levels in hypertrophic cardiomyopathy patients with HFpEF — Europe PMC PMID:40918188},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40918188},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3dba3c618271; sha256 f857a1ee9efd4054a9aeb6959c24d7ceff49a2693d3968f63c2d16ab228c7db2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40918188. Agents can read the archived copy with the MCP tool read_document.